Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Transplantation. 2010 Nov 15;90(9):993-9. doi: 10.1097/TP.0b013e3181f6a058.
Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation.
We invited 101 OLKDs for follow-up health evaluation.
Thirty-six subjects (35.6%) completed evaluation at 6.8±1.5 years postdonation. The mean estimated glomerular filtration rate (eGFR) using the abbreviated modification of diet in renal disease (MDRD) equation (MDRD-eGFR) at follow-up was 72.1±16.3 (range: 42-106) mL/min per 1.73 m, and 47.2% of subjects had an MDRD-eGFR of 30 to 59. The absolute decrease in MDRD-eGFR from the time of donation to follow-up was 27.2 ± 13.1 mL/min per 1.73 m (P<0.001 on paired t test), which represents a 29.2% drop in the serial MDRD-eGFRs. Seven subjects (19.4%) had microalbuminuria (30-300 μg/mg creatinine). Subjects with microabuminuria were more likely to have MDRD-eGFR of less than 60 mL/min per 1.73 m (P=0.021). Subjects whose body mass index was greater than or equal to 35 kg/m (n=14) were found to have an absolute decrement in MDRD-eGFR similar to those with body mass index less than 35 kg/m (31.5 ± 15.6 and 24.7 ± 11.0 mL/min/1.73 m, respectively; P=not significant). Fifteen (41.6%) were hypertensive at follow-up.
On medium-term follow-up, a large proportion of OLKDs will have a MDRD-eGFR of less than 60 mL/min per 1.73 m, and the likelihood increases markedly among those who develop microalbuninuria. This raises concern for hyperfiltration injury. Furthermore, OLKDs experience a substantial incidence of hypertension. Caution is advised in selecting OLKDs pending further data on long-term outcomes.
对于肥胖活体供肾者(OLKD)的长期预后,我们知之甚少。本研究旨在描述 OLKD 捐献后数年的肾脏结局。
我们邀请了 101 名 OLKD 进行随访健康评估。
36 名受试者(35.6%)在捐献后 6.8±1.5 年完成了评估。使用简化肾脏病膳食改良公式(MDRD)估算的肾小球滤过率(eGFR)(MDRD-eGFR)在随访时为 72.1±16.3(范围:42-106)mL/min/1.73m,47.2%的受试者的 MDRD-eGFR 为 30 至 59。与捐献时相比,MDRD-eGFR 在随访时的绝对下降为 27.2±13.1 mL/min/1.73m(配对 t 检验,P<0.001),这代表 MDRD-eGFR 的连续下降了 29.2%。7 名受试者(19.4%)有微量白蛋白尿(30-300μg/mg 肌酐)。微量白蛋白尿的受试者更有可能出现 MDRD-eGFR 低于 60 mL/min/1.73m(P=0.021)。体重指数(BMI)大于或等于 35 kg/m(n=14)的受试者发现,与 BMI 小于 35 kg/m 的受试者相比,MDRD-eGFR 的绝对下降量相似(分别为 31.5±15.6 和 24.7±11.0 mL/min/1.73m,P=无显著差异)。15 名(41.6%)受试者在随访时患有高血压。
在中期随访中,很大一部分 OLKD 的 MDRD-eGFR 将低于 60 mL/min/1.73m,而在出现微量白蛋白尿的患者中,这一可能性显著增加。这引起了对高滤过损伤的关注。此外,OLKD 发生高血压的发生率相当高。在等待进一步的长期结果数据时,应谨慎选择 OLKD。